| abstract |
The present invention provides application of the pazopanib hydrochloride in preparation treatment pulmonary fibrosis disease drug, a kind of pharmaceutical composition is additionally provided, includes pazopanib hydrochloride and pazopanib hydrochloride pharmaceutically acceptable salt, ester, hydrate or their combination and auxiliary material.Pazopanib hydrochloride has good effect to pulmonary fibrosis in the present invention, has no adverse reaction, and can slow down the mouse pulmonary fibrosis of bleomycin induced, provides good application prospect for treatment, alleviation or improvement pulmonary fibrosis disease. |